In detail, 33 analyses, which involved in Brain and CNS cancer, Breast cancer, Lymphoma, Myeloma and many other kinds of cancers, showed statistically significant higher NEO1 mRNA expression levels in tumors, while 27 analyses, such as in Bladder cancer, Colorectal cancer and Kidney cancer, showed lower expression. The gene discussed is NEO1; the disease is urinary bladder carcinoma.